LU86457A1 - Systeme d'application endonasal - Google Patents

Systeme d'application endonasal Download PDF

Info

Publication number
LU86457A1
LU86457A1 LU86457A LU86457A LU86457A1 LU 86457 A1 LU86457 A1 LU 86457A1 LU 86457 A LU86457 A LU 86457A LU 86457 A LU86457 A LU 86457A LU 86457 A1 LU86457 A1 LU 86457A1
Authority
LU
Luxembourg
Prior art keywords
calcitonin
application system
endonasal
gelatin
nostril
Prior art date
Application number
LU86457A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU86457A1 publication Critical patent/LU86457A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU86457A 1985-06-04 1986-06-04 Systeme d'application endonasal LU86457A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8514090 1985-06-04
GB858514090A GB8514090D0 (en) 1985-06-04 1985-06-04 Organic compounds

Publications (1)

Publication Number Publication Date
LU86457A1 true LU86457A1 (fr) 1987-01-13

Family

ID=10580163

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86457A LU86457A1 (fr) 1985-06-04 1986-06-04 Systeme d'application endonasal

Country Status (21)

Country Link
US (1) US4988512A (es)
JP (1) JPS61282320A (es)
KR (1) KR870000066A (es)
AU (1) AU5824786A (es)
BE (1) BE904863A (es)
CH (1) CH668913A5 (es)
DE (1) DE3617728A1 (es)
DK (1) DK259186A (es)
ES (1) ES8801130A1 (es)
FR (1) FR2582511B1 (es)
GB (3) GB8514090D0 (es)
GR (1) GR861422B (es)
HU (1) HU199300B (es)
IL (1) IL78980A0 (es)
IT (1) IT1214683B (es)
LU (1) LU86457A1 (es)
NL (1) NL8601285A (es)
NZ (1) NZ216393A (es)
PT (1) PT82691B (es)
SE (1) SE8602530L (es)
ZA (1) ZA864164B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
DE3726517A1 (de) * 1986-08-18 1988-03-03 Sandoz Ag Nasale zusammensetzungen, welche octreotid enthalten
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
DE4115849A1 (de) * 1991-05-15 1992-11-19 Lohmann Therapie Syst Lts Penetrationsfoerdernde substanz
US5656590A (en) * 1991-05-24 1997-08-12 Amylin Pharmaceuticals, Inc. Treatment of anorexia and related states
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
EP0621775B1 (de) * 1992-01-17 1997-08-06 ALFATEC-PHARMA GmbH Peptidarzneistoffe enthaltende pellets und ihre herstellung sowie deren verwendung
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
GB9623205D0 (en) * 1996-11-07 1997-01-08 Eurand Int Novel pharmaceutical compositions
AU741072B2 (en) 1998-02-13 2001-11-22 Vetoquinol Usa, Inc. Drug delivery system
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6759393B1 (en) 1999-04-12 2004-07-06 Pfizer Inc. Growth hormone and growth hormone releasing hormone compositions
US7812120B2 (en) 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
WO2005097210A1 (en) * 2004-03-26 2005-10-20 The University Of Utah Research Foundation Bioresponsive polymer system for delivery of microbicides
US7396936B1 (en) 2004-11-09 2008-07-08 Kemia, Inc. Modulators of calcitonin and amylin receptor activity

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US820948A (en) * 1905-01-23 1906-05-22 Edward Baum Device fot treating the nasal passages.
US3234091A (en) * 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
DE1617564A1 (de) * 1966-12-03 1971-04-01 Rudolf Kisro Arzneimitteltraeger
DK135268A (es) * 1973-02-09
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
JPS576403A (en) * 1980-06-12 1982-01-13 Toshiba Corp Recording and reproducing device
GB2090535B (en) * 1981-01-06 1984-09-19 Osman Mohammad Fekry Medical inserts
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
FR2537980B1 (fr) * 1982-12-17 1986-12-19 Sandoz Sa Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules

Also Published As

Publication number Publication date
IT8648098A0 (it) 1986-06-04
FR2582511A1 (fr) 1986-12-05
GB8514090D0 (en) 1985-07-10
GB8906584D0 (en) 1989-05-04
GR861422B (en) 1986-10-01
DK259186A (da) 1986-12-05
US4988512A (en) 1991-01-29
BE904863A (fr) 1986-12-03
NL8601285A (nl) 1987-01-02
ES555676A0 (es) 1988-01-01
DK259186D0 (da) 1986-06-02
KR870000066A (ko) 1987-02-16
GB8613284D0 (en) 1986-07-09
FR2582511B1 (fr) 1989-05-26
SE8602530D0 (sv) 1986-06-04
GB2213377A (en) 1989-08-16
SE8602530L (sv) 1986-12-05
DE3617728A1 (de) 1986-12-04
AU5824786A (en) 1986-12-11
ZA864164B (en) 1988-01-27
GB2176105A (en) 1986-12-17
GB2176105B (en) 1990-03-07
PT82691B (en) 1988-05-03
IT1214683B (it) 1990-01-18
CH668913A5 (de) 1989-02-15
ES8801130A1 (es) 1988-01-01
JPS61282320A (ja) 1986-12-12
NZ216393A (en) 1989-08-29
IL78980A0 (en) 1986-09-30
PT82691A (en) 1986-07-01
HUT49288A (en) 1989-09-28
HU199300B (en) 1990-02-28

Similar Documents

Publication Publication Date Title
LU86457A1 (fr) Systeme d'application endonasal
US6375975B1 (en) Pharmaceutical compositions for buccal and pulmonary application
CA2410065C (en) Micellar pharmaceutical compositions for buccal and pulmonary application
CA2354148C (en) Aerosol formulations for buccal and pulmonary application
JP4499282B2 (ja) 混合ミセル状薬剤の移送システム及び調製方法
US6436367B1 (en) Aerosol formulations for buccal and pulmonary application
FR2681326A1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
WO2011141685A2 (fr) Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants
MX2009002041A (es) Formulaciones galenicas de aliskiren.
CA2494132C (en) Pharmaceutical composition, metered dose dispenser containing same, and use of pharmaceutical composition and metered dose dispenser in administering pharmaceutical agent to oral membranes
EP1338272A1 (en) Aerosol formulations for buccal and pulmonary application comprising chenodeoxycholate or deoxycholate
CN111265497B (zh) 口腔载药贴膜及其制备方法、口腔载药贴膜组件及其制备方法
EP4262753B1 (fr) Produit pharmaceutique, son procédé de préparation et ses utilisations
BE1001748A4 (fr) Compositions pharmaceutiques pour l'administration par voie nasale.
WO2005058289A1 (fr) Technique de preparation de produit d'hinalation en poudres deshydratees intranasale de calcitonine
AU2003259466B2 (en) Methods of administering and enhancing absorption of pharmaceutical agents